Tumor index can identify breast cancer patients' drug response
Researchers at The Hong Kong Polytechnic University (PolyU) have developed an imaging biomarker, the Tumour Heterogeneity Index (THI), which enables noninvasive assessment of breast cancer patients' response to AKT inhibitors before treatment, helping clinicians identify patients most likely to benefit from therapy. The study found that patients with a high THI achieved an estimated pathological…
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Vision-language AI agent could help radiologists interpret ultrasounds faster and more accurately
United Kingdom
-
High School Fills Entire Football Field With Groceries to Replenish New Jersey Food Banks
United Kingdom
-
Clot removal days after a stroke could help more patients recover, but the procedure is not without risks
United Kingdom
-
Newly discovered pathway fuels production of cancer-driving proteins
United Kingdom
-
Hero Support Dog Saves Husband’s Life After Alerting Deaf Owner to His Deadly Midnight Fall Down Stairs
United Kingdom
-
Common pesticide linked to 2.5 times the risk of Parkinson’s disease
United States
-
Scientists use sound waves to deliver a new attack on deadly brain cancer
United States
-
'Grasping at straws': Judge dismisses Trump suit against Wall Street Journal over Epstein letter
United States